BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 32418203)

  • 1. Malignant melanotic Xp11 neoplasms exhibit a clinicopathologic spectrum and gene expression profiling akin to alveolar soft part sarcoma: a proposal for reclassification.
    Wang XT; Fang R; Zhang RS; Ye SB; Li R; Wang X; Pan R; Liu C; Chen JY; Zhao M; Teng XD; Yu WJ; Li YJ; Wang FH; Zhang JG; Yang QC; Zhang YS; Lu ZF; Ma HH; Zhou XJ; Xia QY; Rao Q
    J Pathol; 2020 Aug; 251(4):365-377. PubMed ID: 32418203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma: a distinctive tumor entity previously included among renal cell carcinomas of children and adolescents.
    Argani P; Antonescu CR; Illei PB; Lui MY; Timmons CF; Newbury R; Reuter VE; Garvin AJ; Perez-Atayde AR; Fletcher JA; Beckwith JB; Bridge JA; Ladanyi M
    Am J Pathol; 2001 Jul; 159(1):179-92. PubMed ID: 11438465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melanotic Xp11 translocation renal cancer: a case with PSF-TFE3 gene fusion and up-regulation of melanogenetic transcripts.
    Chang IW; Huang HY; Sung MT
    Am J Surg Pathol; 2009 Dec; 33(12):1894-901. PubMed ID: 19809274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular cytogenetic analysis for TFE3 rearrangement in Xp11.2 renal cell carcinoma and alveolar soft part sarcoma: validation and clinical experience with 75 cases.
    Hodge JC; Pearce KE; Wang X; Wiktor AE; Oliveira AM; Greipp PT
    Mod Pathol; 2014 Jan; 27(1):113-27. PubMed ID: 23828314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Melanotic Xp11 translocation renal cancer: report of a case with a unique intratumoral sarcoid-like reaction.
    Ritterhouse LL; Cykowski MD; Hassell LA; Slobodov G; Bane BL
    Diagn Pathol; 2014 Apr; 9():81. PubMed ID: 24735727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An adult case of melanotic Xp11 translocation renal cancers: distinct entity or sub-entity?
    Varinot J; Camparo P; Beurtheret S; Barreda E; Compérat E
    Int J Surg Pathol; 2011 Jun; 19(3):285-9. PubMed ID: 21427096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Melanotic Xp11 translocation renal cancers: a distinctive neoplasm with overlapping features of PEComa, carcinoma, and melanoma.
    Argani P; Aulmann S; Karanjawala Z; Fraser RB; Ladanyi M; Rodriguez MM
    Am J Surg Pathol; 2009 Apr; 33(4):609-19. PubMed ID: 19065101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The der(17)t(X;17)(p11;q25) of human alveolar soft part sarcoma fuses the TFE3 transcription factor gene to ASPL, a novel gene at 17q25.
    Ladanyi M; Lui MY; Antonescu CR; Krause-Boehm A; Meindl A; Argani P; Healey JH; Ueda T; Yoshikawa H; Meloni-Ehrig A; Sorensen PH; Mertens F; Mandahl N; van den Berghe H; Sciot R; Dal Cin P; Bridge J
    Oncogene; 2001 Jan; 20(1):48-57. PubMed ID: 11244503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetics of rare mesenchymal tumors: implications for targeted treatment in DFSP, ASPS, CCS, GCTB and PEComa.
    Rutkowski P; Przybył J; Świtaj T
    Int J Biochem Cell Biol; 2014 Aug; 53():466-74. PubMed ID: 24704529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melanotic PEComa: A Rare But Distinctive Subtype Analyzed in a Series of 7 Cases.
    de la Fouchardiere A; Papke DJ; Pissaloux D; Russell-Goldman E; Tirode F; Fletcher CDM; Hanna J
    Am J Surg Pathol; 2024 Jan; 48(1):88-96. PubMed ID: 38117287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant nuclear immunoreactivity for TFE3 in neoplasms with TFE3 gene fusions: a sensitive and specific immunohistochemical assay.
    Argani P; Lal P; Hutchinson B; Lui MY; Reuter VE; Ladanyi M
    Am J Surg Pathol; 2003 Jun; 27(6):750-61. PubMed ID: 12766578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual-color, break-apart FISH assay on paraffin-embedded tissues as an adjunct to diagnosis of Xp11 translocation renal cell carcinoma and alveolar soft part sarcoma.
    Zhong M; De Angelo P; Osborne L; Keane-Tarchichi M; Goldfischer M; Edelmann L; Yang Y; Linehan WM; Merino MJ; Aisner S; Hameed M
    Am J Surg Pathol; 2010 Jun; 34(6):757-66. PubMed ID: 20421778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TFE3 break-apart FISH has a higher sensitivity for Xp11.2 translocation-associated renal cell carcinoma compared with TFE3 or cathepsin K immunohistochemical staining alone: expanding the morphologic spectrum.
    Rao Q; Williamson SR; Zhang S; Eble JN; Grignon DJ; Wang M; Zhou XJ; Huang W; Tan PH; Maclennan GT; Cheng L
    Am J Surg Pathol; 2013 Jun; 37(6):804-15. PubMed ID: 23598965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mammalian target of rapamycin pathway activity in alveolar soft part sarcoma.
    Reis H; Hager T; Wohlschlaeger J; Bauer S; Katenkamp K; Katenkamp D; Baba HA
    Hum Pathol; 2013 Oct; 44(10):2266-74. PubMed ID: 23871289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of TRIM63 RNA in situ hybridization (RNA-ISH) as a potential biomarker for alveolar soft-part sarcoma (ASPS).
    Taylor AS; Mannan R; Pantanowitz L; Chinnaiyan AM; Dhanasekaran SM; Hrycaj S; Cao X; Chan MP; Lucas D; Wang XM; Mehra R
    Med Oncol; 2024 Feb; 41(3):76. PubMed ID: 38393424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perivascular epithelioid cell tumor (PEComa) of the urinary bladder associated with Xp11 translocation.
    Russell CM; Buethe DD; Dickinson S; Sexton WJ
    Ann Clin Lab Sci; 2014; 44(1):91-8. PubMed ID: 24695481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malignant perivascular epithelioid cell neoplasm (PEComa) of the urinary bladder with TFE3 gene rearrangement: clinicopathologic, immunohistochemical, and molecular features.
    Williamson SR; Bunde PJ; Montironi R; Lopez-Beltran A; Zhang S; Wang M; Maclennan GT; Cheng L
    Am J Surg Pathol; 2013 Oct; 37(10):1619-26. PubMed ID: 23797724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of a TFE3 break-apart FISH assay for Xp11.2 translocation renal cell carcinomas.
    Mosquera JM; Dal Cin P; Mertz KD; Perner S; Davis IJ; Fisher DE; Rubin MA; Hirsch MS
    Diagn Mol Pathol; 2011 Sep; 20(3):129-37. PubMed ID: 21817901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update on selected renal cell tumors with clear cell features. With emphasis on multilocular cystic clear cell renal cell carcinoma.
    Montironi R; Mazzucchelli R; Scarpelli M; Lopez-Beltran A; Cheng L
    Histol Histopathol; 2013 Dec; 28(12):1555-66. PubMed ID: 23893851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Xp11 translocation renal cell carcinoma.
    Ross H; Argani P
    Pathology; 2010 Jun; 42(4):369-73. PubMed ID: 20438411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.